Home›Stock Screener›Sundaram Multi Pap

Sundaram Multi Pap Share Price Today | Stock Price & Sundaram Multi Pap Share Screener

SUNDARAM Stationary
Live Share Price NSE
₹1.09
▲ 0.01 (0.93%)
2026-10-05 00:00:00
Live Share Price BSE
₹1.11
▲ 0.04 (3.74%)
2026-10-05 00:00:00

As of October 5, 2026, the live Sundaram Multi Pap share price (NSE: SUNDARAM) is ₹1.09 on NSE and ₹1.11 on BSE, up 0.93% from the previous close, with shares trading between ₹1.07 and ₹1.11 in today's trading session, and a 52-week range of ₹1.04–₹1.94. Check SUNDARAM annual price range for the annual price range and momentum. Use the Sundaram Multi Pap stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sundaram Multi Pap opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹26 and net income of ₹-3, with EBITDA of ₹1, an operating margin of 3.0% and a profit margin of -11.5%.

Sundaram Multi Pap Market Cap ₹53.55 Cr.
SUNDARAM P/E Ratio (TTM) 15.00
Sundaram Multi Pap P/B Ratio 0.54
EPS (TTM) ₹0.21
Dividend Yield -
Debt to Equity 0.70
SUNDARAM 52 Week High ₹1.94
Sundaram Multi Pap 52 Week Low ₹1.04
Operating Margin 3.00%
Profit Margin -11.54%
SUNDARAM Revenue (TTM) ₹26.00
EBITDA ₹1.00
Net Income ₹-3.00
Total Assets ₹154.00
Total Equity ₹96.00

Sundaram Multi Pap Share Price Chart

Track the current stock price of Sundaram Multi Pap with an interactive chart. Analyse SUNDARAM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sundaram Multi Pap stock quote in one place.

The quote of ₹1.09 sits between the 52-week low of ₹1.04 and the 52-week high of ₹1.94, and the latest session moved 0.93% from the previous close.

Sundaram Multi Pap Company Profile - Fundamental Screener

Screen Sundaram Multi Pap company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUNDARAM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Consumer Goods sector and the Stationary industry, and it trades under ISIN INE108E01023.

Company Details

Classification

Sector Consumer Goods
Industry Stationary
Sub-Sector Stationary
Segment E

Identifiers and Leadership

ISIN INE108E01023

Sundaram Multi Pap Balance Sheet Screener

Screen SUNDARAM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2019, total assets were ₹154, up from ₹152 in 2018.

Latest statistics put total assets at ₹154 and shareholder funds at ₹96, with a leverage ratio of 0.70.

Item 2019 2018 2017 2016 2015

Assets

Total Assets 154 152 178 190 219
Current Assets 93 95 106 87 106
Fixed Assets 60 57 59 92 102

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 1 10 16 24 51
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 96 70 81 82 95
Share Capital 27 27 25 22 22
Reserves & Surplus 48 43 56 60 74

Sundaram Multi Pap Income Statement Screener - Profit & Revenue Analysis

Screen Sundaram Multi Pap income statement and profit fundamentals. Analyze SUNDARAM quarterly results. Sundaram Multi Pap reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2020-Mar, revenue was ₹26 and net profit was ₹-3, equal to earnings per unit of ₹-0.05, at an operating margin of 3%.

In that period expenses were ₹25, interest cost ₹2 and tax ₹0. The next period listed, 2019-Dec, shows revenue of ₹19 and net profit of ₹0.

Item 2020-Mar 2019-Dec 2019-Sept 2019-Jun 2019-Mar 2018-Dec 2018-Sept 2018-Jun

Revenue and Expenses

Revenue 26 19 18 39 32 15 19 36
Expenses 25 16 16 34 27 12 16 30

Operating Costs and Margins

EBITDA 1 3 2 5 5 3 3 6
Operating Profit % 3.00% -6.00% 12.00% 12.00% 15.00% 16.00% 15.00% 14.00%
Depreciation 2 1 1 1 1 1 1 1
Interest 2 2 2 4 2 2 2 2

Profit and Earnings

Profit Before Tax -3 0 -1 1 2 0 1 3
Tax 0 0 0 0 0 0 0 0
Net Profit -3 0 -1 1 2 0 1 3
EPS -0.05 0.00 -0.03 0.03 0.04 0.00 0.03 0.12

Sundaram Multi Pap Cash Flow Screener - Liquidity Fundamentals

Screen SUNDARAM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2019-March, operating activities generated ₹8.

Over the same period, investing activities used ₹4 and financing activities used ₹3.

Item 2019-March 2018-March 2017-March 2016-March 2015-March

Cash from Operations and Investing

Operating Activities 8 5 2 23 26
Investing Activities -4 5 1 9 19

Financing and Net Cash

Financing Activities -3 -9 -4 -32 -44
Net Cash Flow 0 0 -1 0 0

Sundaram Multi Pap Shareholding Pattern Screener

See Sundaram Multi Pap shareholding pattern with promoter, FII, and DII holdings. Check Sundaram Multi Pap promoter holding and ownership changes for SUNDARAM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 31.11%, foreign institutions 0.00%, domestic institutions 0.05% and the public 60.62%, spread across 94,736 shareholders.

The shareholder count was 94,736 in 2026-Mar, compared with 94,464 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 31.11% 31.11% 31.11% 31.11% 31.11% 31.11% 31.11% 31.11%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 60.62% 61.98% 59.64% 60.13% 60.25% 60.21% 59.06% 59.57%
Other Holding 8.21% 6.86% 9.20% 8.71% 8.59% 8.63% 9.78% 9.27%
Shareholder Count 94,736 94,464 94,834 95,643 95,597 95,222 73,477 79,643

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sundaram Multi Pap. Sundaram Multi Pap dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Sundaram Multi Pap.

Sundaram Multi Pap Stock Index Membership - Nifty & Sensex

See which indices include Sundaram Multi Pap stock. Check SUNDARAM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Sundaram Multi Pap is not part of any tracked indices.
Only major market indices are tracked in our system.

Sundaram Multi Pap Market Events Screener - Corporate Actions

Get Sundaram Multi Pap corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sundaram Multi Pap stock events that may affect SUNDARAM share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 25, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-29 2026-09-29 Annual General Meeting NA -5.00%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -4.00%
2026-05-25 2026-05-25 Quarterly Result Announcement NA 0.00%
2026-02-14 2026-02-14 Quarterly Result Announcement NA 2.44%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -1.55%
2025-11-12 2025-11-12 Extraordinary General Meeting NA 2.16%
2025-09-29 2025-09-29 Annual General Meeting NA -5.37%
2025-08-25 2025-08-25 Quarterly Result Announcement NA 2.50%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 0.00%
2025-05-22 2025-05-22 Quarterly Result Announcement NA 10.26%
2025-02-24 2025-02-24 Extraordinary General Meeting NA -2.23%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -2.63%
2025-01-24 2025-01-24 Extraordinary General Meeting NA 0.87%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -2.24%
2024-09-27 2024-09-27 Annual General Meeting NA -3.92%

Sundaram Multi Pap Competitors Screener - Peer Stocks Comparison

Screen SUNDARAM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 8 companies in the Consumer Goods sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
DOMS Industries 12,420 56.02 2,345 21.17% 240 31.48
Flair Writing Industries 2,477 17.72 1,271 15.07% 141 39.20
Kokuyo Camlin 749 34.83 690 9.01% 15 34.96
Kshitij Polyline 99 32.07 45 2.17% 4 66.74
Alkosign 66 -13.12 27 -9.43% 1 49.92
Sundaram Multi Pap 54 102 -8.63% 7 33.90
Gala Global Products 7 -1.37 18 -56.09% -7 44.38
Vasa Retail & Overseas 2 -25.36 0 % 0 26.63

Sundaram Multi Pap Company Announcements - News & Reports Screener

Screen SUNDARAM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated September 2, 2026 and September 2, 2026.

Date Update Actions
Closure of Trading Window -
2026-09-02 Intimation Of Book Closure Dates For The Purpose Of 32Nd Annual General Meeting -
2026-09-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-01 Notice Of 32Nd Annual General Meeting Of The Company To Be Held On September 29 2026 -
2026-09-01 Reg. 34 (1) Annual Report. -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-08-13 Board Meeting Outcome for Outcome Of Board Meeting Held On August 13 2026 -
2026-08-13 Outcome Of Board Meeting Held On August 13 2026 -
2026-07-31 Board Meeting Intimation for Meeting Scheduled To Be Held On August 13 2026. -
2026-07-28 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-07-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -
2026-05-29 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-25 Appointment Of An Internal Auditor Of The Company For The Financial Year 2026-2027 -
2026-05-25 Board Meeting Outcome for Outcome Of Board Meeting Held On May 25 2026 -
2026-05-25 Outcome Of Board Meeting Held On May 25 2026 -
2026-05-15 Board Meeting Intimation for Declaration Of Audited Standalone Financial Results Of The Company. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1.09, within a 52-week range of ₹1.04 to ₹1.94. The P/E ratio is 15.00 and the P/B ratio is 0.54, with earnings per unit of ₹0.21. Market capitalisation stands at ₹53.55 Cr. The company operates in the Consumer Goods sector, in the Stationary industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 8 income statement periods, 5 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.